Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese Price Revision Cycle Yields Progress Amidst Obstinacy – AdvaMed

This article was originally published in The Gray Sheet

Executive Summary

U.S. device industry reps expect Japanese "R-zone" price cuts to more closely approximate market conditions than foreign average pricing (FAP) revisions
Advertisement

Related Content

Commerce Department Offers Exporting Aid To Small Medical Device Firms
Commerce Department Offers Exporting Aid To Small Medical Device Firms
New Japanese Agency Will Accept STED; MHLW Retains Payment Control
New Japanese Agency Will Accept STED; MHLW Retains Payment Control
Cypher in Japan
No Fooling: Japanese User Fees, Revised Reimbursement Rates Debut April 1
No Fooling: Japanese User Fees, Revised Reimbursement Rates Debut April 1
Emerging Trade Pacts Offer Opportunities In Face Of DRG Payment Woes – Ubl
Japanese Foreign Reference Pricing Advisory Process Begins For 2004
Japanese Foreign Reference Pricing Advisory Process Begins For 2004
Advertisement
UsernamePublicRestriction

Register

MT019831

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel